Smital Shah insider trades

Open-market stock purchases and sales by Smital Shah, Chief Fin. and Bus. Officer at Lyell Immunopharma, Inc, from SEC Form 4 filings since Apr 15, 2021.

Recent trades

DateStockTradeValue
Mar 9, 2026LYEL Lyell Immunopharma, IncBought (not open market)—

Companies traded

  • LYEL Lyell Immunopharma, Inc: other filings, last Mar 9, 2026
  • PLRX Pliant Therapeutics, Inc: other filings, last Jun 13, 2024
  • GRPH Graphite Bio, Inc: 1 buy, last Jul 19, 2023

Get free alerts when Smital Shah files a new trade →